Provided by Tiger Trade Technology Pte. Ltd.

vTv Therapeutics

31.86
-1.4300-4.30%
Post-market: 31.860.00000.00%16:27 EDT
Volume:46.34K
Turnover:1.50M
Market Cap:125.46M
PE:-30.18
High:33.00
Open:33.00
Low:31.85
Close:33.29
52wk High:44.00
52wk Low:18.97
Shares:3.94M
Float Shares:2.42M
Volume Ratio:1.65
T/O Rate:1.92%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0558
EPS(LYR):-3.2022
ROE:-15.80%
ROA:-10.14%
PB:5.89
PE(LYR):-9.95

Loading ...

vTv Therapeutics Q1 Operating Expenses USD 13.576 Million

THOMSON REUTERS
·
May 14

vTv Therapeutics Inc expected to post a loss of 9 cents a share - Earnings Preview

Reuters
·
May 11

vTv Therapeutics grants 39,500 inducement stock options at $32 exercise price

Reuters
·
May 09

vTv Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
May 09

vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
May 09

vTv Therapeutics to present at H.C. Wainwright BioConnect investor conference

Reuters
·
May 07

vTv Therapeutics to Participate in Upcoming May Investor Conferences

GlobeNewswire
·
May 07

vTv Therapeutics announces annual shareholder meeting

Reuters
·
Apr 29

vTv Therapeutics grants 4,000 inducement stock options at USD 39.54 per share

Reuters
·
Apr 08

vTv Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Apr 08

vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Apr 08

Analysts’ Opinions Are Mixed on These Healthcare Stocks: vTv Therapeutics (VTVT) and CSPC Pharmaceutical Group (OtherCHJTF)

TIPRANKS
·
Mar 27

vTv Therapeutics to Participate in the 38th Annual ROTH Conference

GlobeNewswire
·
Mar 16

Evercore ISI Initiates vTv Therapeutics at Outperform With $44 Price Target

MT Newswires Live
·
Mar 12

vTv Therapeutics Price Target Maintained With a $49.00/Share by BTIG

Dow Jones
·
Mar 12

vTv Therapeutics price target raised to $55 from $35 at Alliance Global

TIPRANKS
·
Mar 11

Analysts Conflicted on These Healthcare Names: MoonLake Immunotherapeutics (MLTX), Sarepta Therapeutics (SRPT) and vTv Therapeutics (VTVT)

TIPRANKS
·
Mar 11

vTv Therapeutics Inc : Alliance Global Partners Raises Target Price to $55 From $35

THOMSON REUTERS
·
Mar 11

Buy Rating on vTv Therapeutics Underpinned by Late-Stage T1D Catalyst, Strengthened Balance Sheet, and Diversified Partnership-Driven Upside

TIPRANKS
·
Mar 11

vTv Therapeutics Highlights Cadisegliatin Phase 3 and Cash Runway

TIPRANKS
·
Mar 11